PUBLIC PROCUREMENT NOTICEExternal opportunity
Preparing English translation…
Finland – Pharmaceutical products – Amivantamabi-injektionesteitä (Rybrevant® 1600 mg, 2240 mg, 2400 mg ja 3520 mg inj.neste) koskeva suorahankinta ajalle 1.9.2026–31.12.2027
Amivantamabi-injektionesteitä (Rybrevant® 1600 mg, 2240 mg, 2400 mg ja 3520 mg inj.neste) koskeva suorahankinta ajalle 1.9.2026–31.12.2027 Varsinais-Suomen hyvinvointialueen lääkehankintarenkaalle. Procedure: neg-wo-call. Review the origina
Opportunity description
Amivantamabi-injektionesteitä (Rybrevant® 1600 mg, 2240 mg, 2400 mg ja 3520 mg inj.neste) koskeva suorahankinta ajalle 1.9.2026–31.12.2027 Varsinais-Suomen hyvinvointialueen lääkehankintarenkaalle. Procedure: neg-wo-call. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Buyer Sign in to view
Response deadline Sign in to view
Delivery Sign in to view
Estimated value Sign in to view
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.